Alvaro Morales, MD
Professor, Departments of Urology & Oncology, Queen's University, Kingston, Ontario; Urologist, Kingston General Hospital, Kingston, Ontario
Degrees
| 1964 |
Universidad Javeriana, Bogota, Colombia, M.D. Degree (CumLaude) |
| 1972 |
Fellowship of Royal College of Surgeons of Canada |
| 1975 |
Fellowship of American College of Surgeons |
| 1978 |
Diplomate American Board of Urology |
Books Published
Erectile Dysfunction - Issues in Current Pharmacotherapy, Edited by Alvaro Morales, Martin Dunitz Publishers Ltd., London, U.K., 1998.
Honors (partial list)
1997-2002
Chairman, Global Erectile Dysfunction Advisory Council
1998
President, The Northeastern Section of the American Urological Association
1998-1999
Chairman of Ethics & Education & Socio-cultural Aspects Committees First International Consultation on Erectile Dysfunction (World Health Organization)
1998
Executive member, International Society for Impotence Research
1999
Lifetime Achievement Award-Presented by the Canadian Urological Association
2000
Honorary Member of the National Academy of Medicine
2001
Slotkin Lecturer - NE section of the AUA meeting, Boca Raton, Florida
2002
Recipient of the SIU-Yamanouchi Award, SIU meeting, Stockholm
2003
Recipient of the Commemorative Medal for the Queen's Golden Jubilee
Top
Papers Presented (partial list)
Nov. 2001
Mycobacterial Cell Wall - DNA Complex (MCC): Cytokine-stimulating and Apoptosis-inducing activity in Bladder Cancer. Perspectives in Bladder Cancer Meeting, Monte Carlo, Monaco
Nov. 2001
Mycobacterial Cell Wall-DNA Complex (MCC): Efficacy, Safety and Mechanisms of Action in Patients with CIS of the Bladder failing First-Line therapy. Perspectives in Bladder Cancer Meeting, Monte Carlo, Monaco
Dec. 2001
An Innovative, Practical & Effective Treatment for Premature Ejaculation: Lidocaine-Prilocaine Spray. NE Section of the AUA Meeting, Boca Raton, Florida
Dec. 2001
The Clinical Diagnosis of Hypogonadism: Is screening Biochemistry necessary? NE Section of the AUA Mtg., Boca Raton, Florida
Feb. 2002
Elevated Apoptosis and cytokine markers in the urine of patients with carcinoma in situ of the Bladder following treatment with a mycobacterial cell wall complex (MCC). 6th International Symposium on Predictive Oncology and Intervention Strategies, Paris, France
Top
Feb. 2002
Co-chairman of Symposium - Hormone Replacement Therapy in the Aging Male. 3rd World Congress on the Aging Male, Berlin, Germany
Feb. 2002
Chairman of Symposium - Alternatives: An Interactive Symposium on Diagnosis and Management of Gender Specific Problems in the Aging Male. 3rd World Congress on the Aging Male, Berlin, Germany
May 2002
From Ancient Times to Modern Times Via William of Saliceto: The History of the Treatment of Hydroceles Reveals a Painful Past. AUA Meeting, Orlando, Florida
May 2002
MCW DNA Complex (MCC) in the Treatment of CIS of the Bladder Refractory to BCG: Efficacy, Safety and Mechanisms of Action. AUA Meeting, Orlando, Florida
May 2002
Chairman of Course on the Aging Male, AUA Meeting, Orlando, Florida
May 2002
The Problem and Why the Urologist Needs to be Involved. Sexual Medicine Society of North America Symposium on Men's Health, AUA Meeting, Orlando, Florida
May 2002
Moderator of Session on ADAM, Sexual Medicine Society of North America Symposium on Men's Health, AUA Meeting, Orlando, Florida
June 2002
Mycobacterial Wall DNA Complex (MCC) in the Treatment of Refractory CIS of the Bladder: Efficacy, Safety and Mechanisms of Action, CUA Meeting, St. John's, Newfoundland
June 2002
Reliability of NMP22 in the Detection of Bladder Cancer, CUA Meeting, St. John's, Newfoundland
Top
June 2002
A Comprehensive Hormonal Evaluation in Patients with Cancer of the Prostate on Long-Term Androgen Suppression with LHRH analogs. CUA Meeting, St. John's, Newfoundland
June 2002
Intraprostatic Administration of BCG in Dogs: A Dose-Range safety study in Dogs. CUA Meeting, St. John's, Newfoundland
Sept. 2002
Mycobacterial Cell Wall DNA (MCC) in the Treatment of Refractory CIS of the Bladder. SIU Meeting, Stockholm
Sept. 2002
Immune Stimulatory and Apoptosis-Inducing Activity of a Mycobacterial Cell Wall Complex (MCC) in Patients with Carcinoma in Situ of the Bladder Refractory to BCG and/or Chemotherapy. SIU Meeting, Stockholm
March 2003
Management of Superficial Bladder Tumours, Congress of the European Association of Urology, Madrid, Spain
April 2003
Chairman of Postgraduate Course on the Aging Male, AUA Meeting, Chicago
April 2003
Poster Presentation - Mycobacterial Cell Wall Complex (MCC) in the Treatment of CIS of the Bladder: 2 Year Follow-up and Dose Escalation Results
June 2003
3-Year Efficacy and Safety of Viagra in Men with Erectile Dysfunction: Results of Canadian Long-term Extension Study. CUA Meeting, Montreal
June 2003
Levitra (Vardenafil) exhibits Long-term Efficacy and Safety for up to 52 weeks, CUA Meeting, Montreal
Sept. 2003
Phase 2 Study on Two Doses (4 and 8) of Mycobacterial Cell Wall-DNA Complex (MCC) in the Treatment of CIS of the Bladder. Northeastern Section of the AUA, Halifax
Feb. 2004
Chair of Symposium - Oral Administration: A Preferred Route of Testosterone Intake. 4th World Congress on the Aging Male, Prague
Top
Feb. 2004
Recommendations for the Diagnosis and Treatment of Late Onset Hypogonadism. 4th World Congress on the Aging Male, Prague
Feb. 2004
Plenary Session on Androgen Treatment and Prostate Safety. 4th World Congress on the Aging Male, Prague
May 2004
Mycobacterium Phlei Cell Wall Extract for the Treatment of Superficial Bladder Cancer: Final Results of a Phase 2 Trial, American Urological Association Meeting, San Francisco
May 2004
Should we have a Moratorium on ART until more information is available? American Urological Association Meeting, San Francisco
May 2004
Practical Approach to Andropause (ADAM) and Androgen Therapy. Course given at the American Urological Association Meeting, San Francisco
May 2004
Androgen Replacement in the Aging Male, Panel Moderator, American Urological Association Meeting, San Francisco
May 2004
Andropause: Issues Regarding Testosterone Replacement Therapy in Older Men. Geriatric Urological Society Meeting. at the AUA, San Francisco
June 2004
A New Approach to the Treatment of Superficial Bladder Cancer, CUA Meeting, Whistler, B.C.
June 2004
Sustained Efficacy and Tolerability of Levitra (Vardenafil) over 2 years in Men with Erectile Dysfunction. CUA Meeting, Whistler, B.C.
June 2004
Management of Cystitis/Non-Malignant Inflammatory Conditions of the Bladder and the Use of Intravesical Hyaluronate. CUA Meeting, Whistler, B.C.
June 2004
Phase I Study with Mycobacterial Cell Wall Extract and Hyaluronic Acid for the Intraprostatic Treatment of Localized Prostate Cancer. CUA Meeting, Whistler, B.C.
Top
###
|
